LLY Eli Lilly and Company
LLY Eli Lilly and Company
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 4 scans as of 2026-10-16 2 bull 2 neutral converging
POC $1,028 · VWAP $1,050 · +19.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster EVP, SVP + 1 other sold $16M, Aug 10–18
Coverage
3 related campaigns
LLY Price Structure
Loading timeframes…
Peers
Every watchlist LLY belongs to, members best 30-day change first — LLY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@peptide-economy
@biotech
@healthcare-scan
@healthcare
@biotech-scan
@insider-universe
Decision history
4 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
News coverage shows Eli Lilly's second-quarter 2026 print had already landed by the time of tonight's pull. Reuters (July 31) reported Lilly beat estimates on resilient demand for its GLP-1 drugs Mounjaro and Zepbound, widening its lead over Novo Nordisk.
full note →Against street estimates
How LLY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about LLY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled today · Oct 17
- Eli Lilly and Company (LLY) stock price, news, quote and history - Yahoo Finance
- LLY - Eli Lilly and Co Earnings Reports, Summaries & Call Transcripts | Morningstar
- Eli Lilly Stock Price | LLY Stock Quote, News, and History | Markets Insider
- Eli Lilly and Company (TSX:LLY) Stock Price & Overview
- Eli Lilly and Company Announces Results Demonstrating Significant Weight Loss with Foundayo At Every Stage of Menopause | MarketScreener
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
LLY research tape
241 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to LLY.
Obesity/GLP-1 vertical: the next-gen trade is an AI-discovery + tools barbell, not a pure drug-developer bet
mega-cap weekly dispersion by climate era — fixed-percent thresholds dilute